Universal Clinical Codes & Terminology Search

Hematology (genetic bleeding disorders) genomic sequence analysis of 51 genes blood buccal swab or amniotic fluid comprehensive

Interrogation device evaluation (in person) carotid sinus baroreflex activation system including telemetric iterative communication with the implantable device to monitor device diagnostics and programmed therapy values with interpretation and report (eg battery status lead impedance pulse amplitude pulse width therapy frequency pathway mode burst mode therapy start/stop times each day); with programming

Hematology (genetic hyperfibrinolysis delayed bleeding) analysis of 9 genes (F13A1 F13B FGA FGB FGG SERPINA1 SERPINE1 SERPINF2 by next-generation sequencing and PLAU by array comparative genomic hybridization) blood buccal swab or amniotic fluid

Percutaneous laminotomy/laminectomy (interlaminar approach) for decompression of neural elements (with or without ligamentous resection discectomy facetectomy and/or foraminotomy) any method under indirect image guidance (eg fluoroscopic CT) with or without the use of an endoscope single or multiple levels unilateral or bilateral; cervical or thoracic

Hematology (genetic platelet disorders) genomic sequence analysis of 43 genes blood buccal swab or amniotic fluid

Percutaneous laminotomy/laminectomy (interlaminar approach) for decompression of neural elements (with or without ligamentous resection discectomy facetectomy and/or foraminotomy) any method under indirect image guidance (eg fluoroscopic CT) with or without the use of an endoscope single or multiple levels unilateral or bilateral; lumbar

Hematology (heparin-induced thrombocytopenia) platelet antibody reactivity by flow cytometry serum

Bronchoscopy rigid or flexible including fluoroscopic guidance when performed; with bronchial thermoplasty 1 lobe

Hematology (inherited thrombocytopenia) genomic sequence analysis of 42 genes blood buccal swab or amniotic fluid

Bronchoscopy rigid or flexible including fluoroscopic guidance when performed; with bronchial thermoplasty 2 or more lobes

Hematology (genetic platelet function disorder) genomic sequence analysis of 31 genes blood buccal swab or amniotic fluid

Transcutaneous electrical modulation pain reprocessing (eg scrambler therapy) each treatment session (includes placement of electrodes)

Hematology (genetic thrombosis) genomic sequence analysis of 12 genes blood buccal swab or amniotic fluid

Cell enumeration using immunologic selection and identification in fluid specimen (eg circulating tumor cells in blood);

Hematology (von Willebrand disease [VWD]) von Willebrand factor (VWF) and collagen III binding by enzyme-linked immunosorbent assays (ELISA) plasma report of collagen III binding

Cell enumeration using immunologic selection and identification in fluid specimen (eg circulating tumor cells in blood); interpretation and report

Hematology (von Willebrand disease [VWD]) von Willebrand factor (VWF) and collagen IV binding by enzyme-linked immunosorbent assays (ELISA) plasma report of collagen IV binding

Percutaneous transcatheter closure of the left atrial appendage with implant including fluoroscopy transseptal puncture catheter placement(s) left atrial angiography left atrial appendage angiography radiological supervision and interpretation

Hematology (von Willebrand disease [VWD]) von Willebrand propeptide enzyme-linked immunosorbent assays (ELISA) plasma diagnostic report of von Willebrand factor (VWF) propeptide antigen level

Percutaneous or open implantation of neurostimulator electrode array(s) subcutaneous (peripheral subcutaneous field stimulation) including imaging guidance when performed cervical thoracic or lumbar; for trial including removal at the conclusion of trial period